Article Details

Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials

Retrieved on: 2021-04-09 05:37:30

Tags for this article:

Click the tags to see associated articles and topics

Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials. View article details on HISWAI: https://www.oaoa.com/news/business/exscientia-announces-first-ai-designed-immuno-oncology-drug-to-enter-clinical-trials/article_7531e1ce-0594-560b-8063-6659259851b1.html

Excerpt

Exscientia, a leading artificial intelligence (AI)-driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up